生长抑素联合泮托拉唑治疗肝硬化合并上消化道出血的效果观察

高成广; 谢峰; 冯亚东

doi:10.3969/j.issn.1001-5256.2016.02.017

生长抑素联合泮托拉唑治疗肝硬化合并上消化道出血的效果观察

DOI: 10.3969/j.issn.1001-5256.2016.02.017

1. 泰州市姜堰中医院内科
2. 江苏省人民医院消化内科

详细信息

中图分类号: R575.2
计量
- 文章访问数: 311
- HTML全文浏览量: 32
- PDF下载量: 257
- 被引次数: 0
出版历程
- 收稿日期: 2015-10-09
- 出版日期: 2016-02-20

Effect of somatostatin combined with pantoprazole in treatment of liver cirrhosis with upper gastrointestinal hemorrhage

Department of Internal Medicine,Jiangyan Hospital of Traditional Chinese Medicine

摘要

摘要: 目的评价生长抑素联合泮托拉唑治疗肝硬化合并上消化道出血的疗效。方法选取2011年1月-2015年8月泰州市姜堰中医院收治的肝硬化合并上消化道出血患者70例,随机分为两组,联合组与对照组各35例。两组患者入院后均给予常规基础治疗,联合组加用生长抑素联合泮托拉唑治疗,对照组予以生长抑素治疗。观察治疗前后两组临床疗效、止血时间、输血量、48 h再出血率、住院时间及不良反应。计量资料组间比较采用t检验,计数资料组间比较采用χ2检验,等级资料组间比较采用Wilcoxon秩和检验。结果联合组的临床疗效明显优于对照组,联合组总有效率94.3%,对照组总有效率62.9%,两组临床疗效差异有统计学意义（χ2=10.27,P<0.05）,联合组显效率为60.0%,对照组显效率34.3%,两组显效率差异无统计学意义（χ2=2.80,P>0.05）;在止血时间、输血量、住院时间方面,联合组明显低于对照组,两组比较差异均有统计学意义（t值分别为9.036、6.419、4.186,P值均<0.05）;联合组48 h再出血率低于对照组,两组间差异无统计学意义（χ2=0.22,P>0.05）;...
- 肝硬化 /
- 食管和胃静脉曲张 /
- 生长抑素 /
- 质子泵抑制剂
Abstract: Objective To investigate the effect of somatostatin( SS) combined with pantoprazole in the treatment of liver cirrhosis with upper gastrointestinal hemorrhage( UGIH). Methods A total of 70 patients with liver cirrhosis and UGIH who were admitted to Jiangyan Hospital of Traditional Chinese Medicine from January 2011 to August 2015 were enrolled and randomized into combination group and control group,with 35 patients in each group. After admission,the patients in both groups were given conventional basic treatment; the patients in the combination group were given SS combined with pantoprazole,and those in the control group were given SS alone. The treatment outcome,time to hemostasis,volume of blood transfusion,48- hour rebleeding rate,length of hospital stay,and adverse events before and after treatment were observed and compared between the two groups. The t- test was applied for comparison of continuous data between groups,the chi- square test was applied for comparison of categorical data between groups,and the Wilcoxon rank sun test was applied for comparison of ranked data between groups. Results The combination group had a significantly better treatment outcome compared with the control group,with overall response rates of 94. 3% and 62. 9%,respectively( χ2= 10. 27,P < 0. 05); the marked response rate was60. 0% in the combination group and 34. 3% in the control group,and showed no significant difference between the two groups( χ2= 2. 80,P > 0. 05); the combination group had a significantly shorter time to hemostasis,a significantly lower volume of blood transfusion,and a significantly shorter length of hospital stay compared with the control group( t = 9. 036,6. 419,and 4. 186,all P < 0. 05); the combination group had a lower 48- hour rebleeding rate than the control group,but the 48- hour rebleeding rate showed no significant difference between the two groups( χ2= 0. 22,P > 0. 05); the incidence rate of adverse events was similar between the two groups and showed no significant difference( χ2= 0. 16,P > 0. 05),and the adverse events in both groups were mild. Conclusion SS combined with pantoprazole has better efficacy than SS alone in the treatment of liver cirrhosis with UGIH. Patients treated with SS combined with pantoprazole have a short time to hemostasis,a low volume of blood transfusion,a low rebleeding rate,and a short length of hospital stay,with no serious adverse events during treatment. The combination therapy is an effective treatment of liver cirrhosis with UGIH.
- liver cirrhosis /
- esophageal and gastric varices /
- somatostatin,proton pump inhibitors /

HTML全文

参考文献(17)

[1]WU JH,LIU XM,YANG JF,et al.Therapeutic effect of pituitrin combined with octreotide in cirrhotic patients with upper gastrointestinal bleeding:an analysis of 60 cases[J].J Qiqihar Uni Med,2013,34(10):1470-1471.(in Chinese)吴建辉,刘小梅,杨京帆,等.垂体后叶素联合奥曲肽治疗肝硬化上消化道出血60例疗效观察[J].齐齐哈尔医学院学报,2013,34(10):1470-1471.

[2]Chinese Society of Infectious Diseases and Parasitology,Chinese Society of Hepatology,Chinese Medical Association.Prevention and treatment of viral hepatitis[J].Chin J Infect Dis,2001,19(1):56-62.(in Chinese)中华医学会传染病与寄生虫病学分会,肝病学分会.病毒性肝炎防治方案[J].中华传染病杂志,2001,19(1):56-62.

[3]LEE HY,LEE HJ,LEE SM,et al.A prospective randomized controlled clinical trial comparing the effects of somatostatin and vasopressin for control of acute vaficeal bleeding in the patients with liver cirrhosis[J].Korean J Intern Med,2003,18(3):161-166.

[4]CHONG H,WANG YZ.Clinical observation on somatostatin combined pantoprazole in treating sereve non-variceal upper gastrointestinal hemorrhage[J].Mod Med J China,2014,16(1):45-47.(in Chinese)常红,王银章.生长抑素联合泮托拉唑治疗非食管胃底静脉曲张性上消化道出血疗效观察[J].中国现代医药杂志,2014,16(1):45-47.

[5]ZHANG GP.Efficacy of somatostatin in treatment of liver cirrhosis complicated by upper gastrointestinal bleeding[J].J Baotou Med Coll,2012,28(6):62-63.(in Chinese)张广萍.生长抑素治疗肝硬化合并上消化道出血疗效观察[J].包头医学院学报,2012,28(6):62-63.

[6]DENG H,QI XS,GUO XZ.UK guidelines on the management of variceal haemorrhage in cirrhotic patients(2015):an excerpt of recommendatoins[J].J Clin Hopatol,2015,31(6):852-854.(in Chinese)邓晗,祁兴顺,郭晓钟.《2015年英国肝硬化静脉曲张出血防治指南》摘译[J].临床肝胆病杂志,2015,31(6):852-854.

[7] ZHAO Y.The curative effect of using omerazole and octreotide alone or jointly in treament of nanvariceal upper gastrointestinal bleeding[D].Shandong University,2011.(in Chinese)赵妍。奥美拉唑、奥曲肽单独与联合应用对非静脉曲张性上消化道出血的疗效[D].山东大学,2011.

[8]CHIU PW,SUNG JJ.Acute nonvafice upper gastrointestinal bleeding[J].Curr Opin Gastroenterol,2010,26(5):425-428.

[9]LIU JH,ZHU FF.Clinical efect observation of combination of octreotide and thrombin in the treatment of cirrhosis with upper gastrointestinal bleeding[J].J Bethune Med Sci,2014,12(1):21-23.(in Chinese)刘建华,朱芬芳.奥曲肽联合凝血酶治疗肝硬化合并上消化道出血疗效观察[J].白求恩医学杂志,2014,12(1):21-23.

[10]ZHAN Q,ZHENG KL,MU HJ.Serum angiotensini-converting enzyme levels and the therapeutic effects of octreotide in esophagcal variceal hemorrhage[J].Am J Med Sci,2011,342(1):20.

[11]LIU L.Analysis of clinical diagnosis and treatment of 48 cases of liver cirrhosis with upper gastrointestinal hemorrhage[J].J Tradit Chin Med Univ Hunan,2014,34(2):8-9.(in Chinese)刘亮.肝硬化并上消化道出血48例临床疗效分析[J].湖南中医药大学学报,2014,34(2):8-9.

[12]VITLIS Z,PAPP M,TORNAI I,et al.Prevention and treatment of esophageal variceal bleeding[J].Orv Hetil,2006,147(51):2455-2463.

[13]ZHANG ZY,ZHOU GW.Drug treatment of variceal bleeding due to portal hypertensio[J].J Abdominal Surg,2014,27(2):89-91.(in Chinese)张正筠,周光文.肝硬化门静脉高压症上消化道出血的药物防[J].腹部外科,2014,27(2):89-91.

[14]HUANG X,YANG L.Clinical observation of different doses of acetic octreotide in the treatment of esophagogastric varicose hemorrhage in patients with liver cirrhosis[J].China Pharm,2014,25(16):1478-1480.(in Chinese)黄欣,杨柳.不同剂量醋酸奥曲肽治疗肝硬化食管胃静脉曲张破裂出血的临床观察[J].中国药房,2014,25(16):1478-1480.

[15]JIANG HB.Clinical treatment of non-variceal upper gastrointestinal bleeding[J].Chin J Mod Drug Appl,2014,8(6):92-93.(in Chinese)姜海波.非静脉曲张性上消化道出血临床治疗观察[J].中国现代药物应用,2014,8(6):92-93.

[16]ZHANG JJ,DING J.The clinical application of octreotide combined with pantoprazole in gastrointestinal ulcer bleeding[J].J Dis Monitor Control,2013,7(8):474-475.(in Chinese)张京菊,丁晶.泮托拉唑联合奥曲肽在消化道溃疡合并出血中的临床应用[J].疾病监测与控制杂志,2013,7(8):474-475.

[17]LI JL,LIANG F,CAO Y.Clinical efficacy of octreotide combined with omeprazole in treatment of non-variceal upper gastrointestinal bleeding[J].Chin J Mod Drug Appl,2014,8(8):165-166.(in Chinese)李久伶,梁峰,曹颖.奥曲肽联合奥美拉唑治疗非曲张静脉上消化道大出血的临床分析[J].中国现代药物应用,2014,8(8):165-166.

施引文献

资源附件(0)

访问统计